Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
EKSO logo EKSO
Upturn stock ratingUpturn stock rating
EKSO logo

Ekso Bionics Holdings Inc (EKSO)

Upturn stock ratingUpturn stock rating
$3.95
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/02/2025: EKSO (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6.75

1 Year Target Price $6.75

Analysts Price Target For last 52 week
$6.75 Target price
52w Low $2.73
Current$3.95
52w High $19.2

Analysis of Past Performance

Type Stock
Historic Profit -33.11%
Avg. Invested days 19
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/02/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 10.32M USD
Price to earnings Ratio -
1Y Target Price 6.75
Price to earnings Ratio -
1Y Target Price 6.75
Volume (30-day avg) 2
Beta 0.89
52 Weeks Range 2.73 - 19.20
Updated Date 09/2/2025
52 Weeks Range 2.73 - 19.20
Updated Date 09/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -6.49

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -75.66%
Operating Margin (TTM) -193.24%

Management Effectiveness

Return on Assets (TTM) -30.17%
Return on Equity (TTM) -96.44%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 9943205
Price to Sales(TTM) 0.7
Enterprise Value 9943205
Price to Sales(TTM) 0.7
Enterprise Value to Revenue 0.68
Enterprise Value to EBITDA 0.46
Shares Outstanding 2611790
Shares Floating 2244727
Shares Outstanding 2611790
Shares Floating 2244727
Percent Insiders 4.95
Percent Institutions 2.76

ai summary icon Upturn AI SWOT

Ekso Bionics Holdings Inc

stock logo

Company Overview

overview logo History and Background

Ekso Bionics Holdings Inc. was founded in 2005 and is based in Richmond, California. It designs, develops, and commercializes exoskeletons for medical and industrial applications. Initially focused on military applications, Ekso Bionics has since transitioned to primarily medical rehabilitation and industrial solutions.

business area logo Core Business Areas

  • Medical: Designs, develops, and sells exoskeletons for rehabilitation of patients with spinal cord injuries, stroke, and other neurological conditions. Products include the EksoNR.
  • Industrial: Develops and sells exoskeletons for use in industrial settings to reduce worker fatigue and injury. Products include the EksoVest.

leadership logo Leadership and Structure

Scott Davis is the CEO. The company operates with a functional organizational structure across engineering, sales, marketing, and operations.

Top Products and Market Share

overview logo Key Offerings

  • EksoNR: An exoskeleton used in rehabilitation clinics for patients with neurological conditions to regain mobility. Competing products include ReWalk Robotics and Cyberdyne. Market share is estimated around 25% within the rehabilitation exoskeleton market, though precise figures are difficult to obtain.
  • EksoVest: An upper-body exoskeleton designed for industrial workers to reduce fatigue and risk of injury during repetitive tasks. Competitors include suitX (now Ottobock) and StrongArm Technologies. Market share data is fragmented and not readily available but estimated around 10-15%.

Market Dynamics

industry overview logo Industry Overview

The exoskeleton market is growing, driven by increasing awareness of the benefits of exoskeletons in rehabilitation and industrial settings. The market is segmented by end-user (medical, industrial, military) and by type of exoskeleton (powered, passive).

Positioning

Ekso Bionics is a key player in the medical and industrial exoskeleton markets, known for its technology and brand recognition. The company is continuously innovating to improve its products and expand its market reach.

Total Addressable Market (TAM)

The TAM for exoskeletons is projected to reach billions of dollars in the coming years. Ekso Bionics is positioned to capture a significant portion of this market through its established products and ongoing innovation. TAM estimates vary widely, but several reports project the global exoskeleton market to reach $2-4 Billion by 2030. Ekso Bionics is striving to capture 10-20% of this growing market.

Upturn SWOT Analysis

Strengths

  • Established brand in the exoskeleton market
  • Strong technological capabilities
  • Focus on both medical and industrial applications
  • FDA cleared products

Weaknesses

  • Limited financial resources compared to larger competitors
  • High product costs
  • Dependence on clinical adoption rates
  • Lack of consistent profitability

Opportunities

  • Expanding applications in new industries
  • Partnerships with healthcare providers and industrial companies
  • Developing more affordable exoskeleton solutions
  • Government funding for exoskeleton research and development

Threats

  • Competition from larger, well-funded companies
  • Regulatory hurdles
  • Slow adoption rates due to high costs
  • Technological advancements rendering current products obsolete

Competitors and Market Share

competitor logo Key Competitors

  • REWK
  • CYBNY

Competitive Landscape

Ekso Bionics has a strong brand and established products but faces competition from larger, well-funded companies. Ekso Bionicsu2019 advantage lies in its specialized expertise and focus on specific applications.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been variable, with periods of rapid growth followed by periods of slower growth. Revenue growth depends on product adoption and market expansion.

Future Projections: Future growth projections would be based on analyst estimates and would be provided if available.

Recent Initiatives: Recent initiatives include expanding sales efforts, developing new exoskeleton models, and pursuing strategic partnerships.

Summary

Ekso Bionics is a key player in the growing exoskeleton market, leveraging its established brand and technological expertise in both medical and industrial sectors. However, the company faces challenges including high product costs, competition from larger entities, and the need for sustained profitability. Strategic partnerships and expansion into new applications are crucial for future growth. Maintaining its technology edge and navigating regulatory hurdles will be essential for success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Industry reports
  • Analyst estimates
  • Press releases

Disclaimers:

The information provided is for informational purposes only and should not be construed as investment advice. Market share estimates are approximate and may vary depending on the source. Financial data is not current and is for illustrative purposes only.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Ekso Bionics Holdings Inc

Exchange NASDAQ
Headquaters San Rafael, CA, United States
IPO Launch date 2014-01-16
CEO & Director Mr. Scott G. Davis
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 61
Full time employees 61

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.